A phase II single-arm pilot study of second-line icotinib treatment in advanced esophageal cancer with EGFR over-expression or amplification

Autor:	Jianming Ying, Junfeng Liu, Jing Huang, Ping Lu, Changwu Ma, Fenlai Tan, Yan Sun, Wei Liu, Ying Liu, Q. Fan
Rok vydání:	2015
Předmět:	Oncology Cancer Research medicine.medical_specialty integumentary system biology business.industry Esophageal cancer medicine.disease Second line Internal medicine Icotinib medicine Over expression biology.protein Advanced esophageal cancer Epidermal growth factor receptor business
Zdroj:	Journal of Clinical Oncology. 33:4044-4044
ISSN:	1527-7755 0732-183X
Popis:	4044 Background: Epidermal growth factor receptor (EGFR) has been reported to be overexpressed in esophageal cancer, suggesting EGFR-directed treatment is a potential option. Here we report the ant...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::5d668fb82f38e0c54220c17151737645 https://doi.org/10.1200/jco.2015.33.15_suppl.4044 Zobrazit plný text záznamu